Archive for the ‘springer retractions’ Category
Here’s the notice in Cancer Immunology, Immunotherapy for “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF:” Read the rest of this entry »
The paper, titled “Further Pieces of Evidence to the Pulmonary Origin of Sevoflurane Escaping to the Operating Room During General Anaesthesia,” appeared in Cell Biochemistry and Biophysics and came from a group at various institutions in Harbin, China.
A diabetes paper that received quite a bit of media attention when it was published in June 2013 was retracted and reissued to fix data errors shortly after publication.
The paper, which showed a steep decline in mortality rates for diabetics in Ontario, Canada, and the UK between 1996 and 2009, was republished in December 2013, with the same conclusion and the errors corrected.
Tardigrades, the most hardy animals on or off planet Earth, can survive boiling, freezing, and even the ravages of outer space.
Unfortunately, some data on water bears’ memories proved to be less long-lasting, earning a retraction for a George Mason University researcher who also published the paper without alerting her co-workers ahead of time.
Here’s the notice for “Suspended animation: effects on short-term and long-term positive associative memory in Hypsibius dujardini,” which first appeared in Invertebrate Neuroscience: Read the rest of this entry »
The first, an article about apartheid, was presented at a student conference and published in the Polyvocia: The SOAS Journal of Graduate Research. It was later retracted because the author “should have used quotation marks around material written verbatim from that source.”
After typing up 96 citations, researchers from the National Institute for Digestive Diseases, I.R.C.C.S. “S. de Bellis,” in Bari, Italy, apparently ran out of steam for the last five, earning themselves a retraction for plagiarism in a literature review of the effects of probiotics on intestinal cancer.
Publishing gadfly demands journal editor’s resignation, then has “fairly incomprehensible” paper rejected
A scientific publishing gadfly who was banned earlier this year from an Elsevier journal for “personal attacks and threats” has had a paper rejected by a Springer journal after he called for the editor’s resignation because of alleged incompetence.
As detailed in a comment left at Retraction Watch, Jaime A. Teixeira da Silva submitted a manuscript titled “One Conjunction, a World of Ethical Difference: How Elsevier, the ICMJE and Neurology Define Authorship” to Science and Engineering Ethics on November 11, 2012. As of last week, despite a number of messages sent to editors of the journal, he had not had a decision on the manuscript.
As a result, on July 14 of this year, Teixeira da Silva sent this letter to journal editor Raymond Spier and to Stephanie Bird, an editorial board member assigned to the manuscript: Read the rest of this entry »
In our coverage Tuesday of the republication of the controversial retracted study of GMOs and rats by Gilles Seralini and colleagues, we wrote this about a strange passage in an editor’s note on the paper:
The republished study was peer-reviewed, according to the press materials, and Seralini confirmed that it was in an email to Retraction Watch. But we were curious what “any kind of appraisal of the paper’s content should not be connoted” meant. We asked Seralini and the editor of Environmental Sciences Europe, Henner Hollert, but neither responded.
Retraction Watch readers may recall that the editor of Food and Chemical Toxicology decided to retract the heavily criticized paper because it was “inconclusive.” The editor, A. Wallace Hayes, claimed that this was consistent with Committee on Publication Ethics (COPE) guidelines, although we and many others disagreed.
Here’s the original abstract of the Food and Chemical Toxicology paper, which has been cited 55 times, according to Thomson Scientific’s Web of Knowledge: Read the rest of this entry »
The article, titled “Strategies for efficient production of heterologous proteins in Escherichia coli,” came from a pair of biochemical engineers from the Indian Institute of Technology-Delhi, in New Delhi, India.